Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
PL

Peter Lamb — 14 Patents

EXExelixis: 13 patents #13 of 312Top 5%
SLSmithkline Beecham Limited: 1 patents #893 of 1,624Top 55%
Oakland, CA: #455 of 4,380 inventorsTop 15%
California: #43,920 of 386,348 inventorsTop 15%
Overall (All Time): #332,869 of 4,157,543Top 9%
14 Patents All Time
Peter Lamb has been granted 14 US patents while listed as an inventor at Exelixis. The first was granted in 2002 and the most recent in April 2025. Peter Lamb ranks #332,869 of 4,157,543 US inventors in our database (top 8.0%). Patent records list Peter Lamb in Oakland, CA, US.

Issued Patents All Time

Showing 1–14 of 14 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12275706 Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer Adrian St. Clair Brown, William P. Gallagher 2025-04-15
11098015 Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer Adrian St. Clair Brown, William P. Gallagher 2021-08-24 $62,606,000
11091440 Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)- N′-(4-fluorophenyl)cyclopropane-1,1 -dicarboxamide, and crystalline forms thereof for the treatment of cancer Adrian St. Clair Brown, William P. Gallagher 2021-08-17 $29,438,000
11091439 Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer Adrian St. Clair Brown, William P. Gallagher 2021-08-17 $29,438,000
11065240 Drug combinations to treat multiple myeloma Dana T. Aftab 2021-07-20 $54,098,000
9809549 Malate salt of N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N′(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer Adrian St. Clair Brown, William P. Gallagher 2017-11-07 $99,311,000
8877776 (L)-malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Adrian St. Clair Brown, William P. Gallagher 2014-11-04 $6,612,000
8802692 Synergistic effects between sphingosine-1-phosphate receptor antagonists and antimicrotubule agents Geetha Shankar, Frauke Bentzien, David Matthews 2014-08-12 $12,150,000
8642584 Method of using PI3K and MEK modulators Dana T. Aftab, A. Douglas Laird, Jean-Francois A. Martini 2014-02-04 $4,986,000
8513266 Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K alpha David Matthews 2013-08-20 $8,669,000
8481001 Combination therapies comprising quinoxaline inhibitors of P13K-alpha for use in the treatment of cancer David Matthews 2013-07-09 $4,294,000
7999006 Methods of using MEK inhibitors 2011-08-16 $13,605,000
7704995 Protein kinase modulators and methods of use Chris A. Buhr, Tae-Gon Baik, Sunghoon Ma, Zerom Tesfai, Longcheng Wang +23 more 2010-04-27 $7,415,000
6498155 Methods of treating thrombocytopenia Juan Luengo 2002-12-24